Radiosynthesis and biodistribution of the S-[18F]fluoroethyl analog of McN5652

Nuclear Medicine and Biology

Volumn 23, Issue 4, 1996, Pages 407-412

  Suehiro, Makiko ^a,b   Greenberg, Joel H ^a   Shiue, Chyng Yann ^a   Gonzalez, Carlos ^a   Dembowski, Barry ^a   Reivich, Martin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Box 28 ^*  (United States)

Author keywords

Analog; Biodistribution; Radiosynthesis; S 18F Fluoroethyl

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; FLUORINE 18; PAROXETINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; PHARMACOKINETICS;

EID: 0030152862     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00013-3     Document Type: Article

References (45)

1. 1. Berger G., Maziere M., Knipper R., Prenant C. and Comar D. (1979) Automated synthesis of carbon-11 labeled radiopharmaceuticals: Imipramine, chlorpromazine, nicotine and methionine. Int. J. Appl. Radiat. Isot. 30, 393-400.
2. 3H]paroxetine as an in vivo ligand for serotonin uptake sites: A quantitative autoradiographic study in the rat brain. Synapse 13, 1-9.
3. 3. Bowen D. M., Allen S. J., Benton J. S., Goodhardt M. J., Haan E. A., Palmer A. M., Sims N. R., Smith C. C. T., Spillane J. A., Esiri M. M., Snowden J. S., Wilcock G. K. and Davison A N. (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J. Neurochem. 41, 266-272.
4. 11C]Methyl)-spiperone, a ligand binding to dopamine receptors: Radiochemical synthesis and biodistribution studies in mice. J. Nucl. Med. 25, 1222-1227.
5. 3H]imipramine binding sites in control and Parkinson brains. Eur. J Pharmacol. 117, 71-80.
6. 18F]fluoroalkyl) spiperone derivatives. Int. J. Appl. Radiat. Isot. 37, 1173-1180.
7. 7. Chi D. Y., Kilbourn M. R., Katzenellenbogen J. A. and Welch M. J. (1987) A rapid and efficient method for the fluoroalkylation of amines and amides: Development of a method suitable for incorporation of the short-lived positron emitting radionuclide fluorine-18. J. Org. Chem. 52, 658-664.
8. 125I]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse 12, 37-46.
9. 2BrF via aminopolyether supported nucleophilic substitution. J. Label. Compd. Radiopharm. 23, 587-595.
10. 10. Dannals R. F., Ravert H. T., Wilson A. A., Scheffel U., Frost J. J. and Wagner H. N., Jr. (1989) Synthesis of a radiotracer for studying serotonin uptake sites: Carbon-11 labeled N-methylparoxetine. J. Label. Compd. Radiopharm. 26, 205-206.
11. 11C]Citalopram. Appl. Radiat. Isot. 31, 541-543.
12. 18F]fluoxetine as a potential radiotracer for serotonin reuptake sites. Appl. Radiat. Isot. 44, 835-842.
13. 13. Halliday G. M., Blumbergs P. C., Cotton R. G. H., Blessing W. W. and Geffen L. B. (1990) Loss of brainstem serotonin-and substance P-containing neurons in Parkinson's disease. Brain Res. 510, 104-107.
14. 18F]-(S)-fluoxetine, a selective serotonin uptake inhibitor. J. Label. Compd. Radiopharm. 32, 703-710.
15. 11C]cyanoimipramine. Nucl. Med. Biol. 14, 587-592.
16. 16. Hume S. P., Pascali C. and Pike V. W. (1991) Citalopram. Labeling with carbon-11 and evaluation in rat as a potential radioligand for in vivo PET studies of 5-HT re-uptake sites. Nucl. Med. Biol. 18, 339-351.
17. 2 receptor affinities of derivatives of spiperone containing aliphatic halogens. Appl. Radiat. Isot. 37, 1181-1188.
18. 18. Kilbourn M. R., Haka M. S., Mulholland G. K., Jewett D. M. and Kuhl D. E., (1989) Synthesis of radiolabeled inhibitors of presynaptic monoamine uptake systems: Fluorine-18 GBR-13119 DA, carbon-11 nisoxetine NE and carbon-11 fluoxetine 5-HT. J. Label. Compd. Radiopharm. 26, 412-414.
19. 3H]imipramine in human brain. J. Neurochem. 37, 267-271.
20. 20. Lasne M. C., Pike V. W. and Turton D. R. (1989) The radiosynthesis of N-methyl-carbon-11-sertraline. App. Radiat. Isot. 40, 147-152.
21. 21. Leysen J. L. (1985) Characterization of serotonin receptor binding sites. In Neuropharmacology of Serotonin (Edited by Green AR), pp. 79-109. Oxford University Press, New York.
22. 22. Maryanoff B. E., McComsey D. F., Gardocki J. F., Shank R. P., Cosranzo M. J., Nortey S.O., Schneider C. R. and Setler P. E. (1987) Pyrroloisoquinoline antidepressants: 2. In-depth exploration of structure-activiry relationships. J. Med. Chem. 30, 1433-1454.
23. 23. Maryanoff B. E., Vaught J. L., Shank R. P., McComsey D. F., Costanzo M. J. and Nortey S. O. (1990). Pyrroloisoquinoline antidepressants: 3. A focus on serotonin. J. Med. Chem. 33, 2793-2797.
24. 11C-Chlorimipramine: Synthesis and analysis. J. Radioanal. Chem. 45, 453-457.
25. 25. Palmer A. M., Francis P. T., Benton J. S., Sim N. R., Mann D. M. A., Neary D., Snowden J. S. and Bowen D. M. (1987) Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48, 8-15.
26. 3H-imipramine binding in the brain of patients with depressive illness. Br. J. Psychiatry 142, 188-192.
27. 27. Porsolt R. D. (1993) Serotonin: Neurotransmirter "a la mode." Pharmacopsychiatry 26, 20-24.
28. 18F]fluoroethyl)spiperone, a new dopamine receptor binding tracer for PET. Nucl. Med. Biol. 13, 617-624.
29. 3H]paroxetine. J. Neurochem. 52, 1605-1612.
30. 30. Scheffel U. and Ricaurte G. A. (1990a) Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: A presynaptic serotonergic positron emission tomography ligand? Brain Res. 527, 89-95.
31. 11C-fluoxetine as in vivo ligands for the serotonin uptake site. J. Nucl. Med. 31, 883-884.
32. 18O]water using anion exchange resin. Appl. Radiat. Isot. 41, 531-533.
33. 33. Shank R. P., Vaught J. L., Pelley K. A., Setler P. E., McComsey D. F. and Maryanoff B. E. (1988) McN-5652: A highly potent inhibitor of serotonin uptake. J. Pharm. Exp. Ther. 247, 1032-1038.
34. 18F]fluoroalkyl derivatives of neurotransmitter receptor active compounds. J. Label. Compd. Radiopharm. 24, 55-64.
35. 35. Stanley M., Virgilio J. and Gershon S. (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216, 1337-1339.
36. 36. Suehiro M., Musachio J. L., Dannals R. F., Mathews W. B., Ravert H. T., Scheffel U. and Wagner H. N. Jr. (1995) An improved method for the synthesis of radiolabeled McN5652 via thioester precursors. Nucl. Med. Biol. 22, 543-545.
37. 37. Suehiro M., Ravert H. T., Scheffel U., Dannals R. F., Wagner H. N. Jr. and Bøgesø K. P. (1994) Radiosynthesis and in vivo evaluation of highly potent indanamine 5-HT uptake blockers as radiotracers for imaging 5-HT uptake sites. Nucl. Med. Biol. 21, 1083-1091.
38. 11C]McN-5652. J. Label. Compd. Radipharm. 31, 841-848.
39. 11C]McN5652-Z. J. Nucl. Med. 34, 120-127.
40. 11C-DDPI. Nucl. Med. Biol. 19, 549-553.
41. 11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Life Sciences 53, 883-892.
42. 18F]fluoropropyl)-paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET. Nucl. Med. Biol. 18, 791-796.
43. 11C](+)McN15652. Synapse 20, 37-43.
44. 44. Vaatstra W. J., Deiman-Van Aalst W.M.A. and Eigeman L. (1981) DU 24565: A quipazine derivative, a potent selective serotonin uptake inhibitor. Eur. J. Pharmacol.. 70, 195-202.
45. 3H-paroxetine binding sites in putamen. Neurology 36, 556-560.